NIKOLE MURRAY: Open Payments
NPI 1255925327 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,290 in 81 payments from 23 companies in 2025. Trend: 2023 $1,309 · 2024 $2,189 · 2025 $2,290
Food & beverage: $2,105Education: $185
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $448 |
| ABBVIE INC. | 9 | $346 |
| UCB, Inc. | 8 | $328 |
| Galderma Laboratories, L.P. | 8 | $226 |
| GENZYME CORPORATION | 7 | $148 |
| PFIZER INC. | 5 | $113 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| Amgen Inc. | 3 | $76 |
| Organon LLC | 4 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
Products named: TREMFYA, Bimzelx, RINVOQ, DUPIXENT, NEMLUVIO, CIBINQO, SKYRIZI, OTEZLA.
Industry payments across MD — which companies pay providers there.
